Cara Therapeutics Inc (CARA)

14.39
0.16 1.10
NASDAQ : Health Care
Prev Close 14.55
Open 14.59
Day Low/High 14.00 / 14.63
52 Wk Low/High 4.26 / 23.61
Volume 537.96K
Avg Volume 1.46M
Exchange NASDAQ
Shares Outstanding 27.28M
Market Cap 401.06M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Here's What 'Superinvestors' Are Doing During the Latest Surge in the Stock Market

Here's What 'Superinvestors' Are Doing During the Latest Surge in the Stock Market

Here's a technical look at how to trade a number of stocks rising with unusual volume flow.

Check Point Software, Sanchez Energy, Aecom Technology: 'Mad Money' Lightning Round

Check Point Software, Sanchez Energy, Aecom Technology: 'Mad Money' Lightning Round

Jim Cramer is bullish on Check Point Software, CyberArk Software, Sanchez Energy and Aecom Technology.

Winners and Losers in the Wake of Apple's Earnings: Cramer's 'Mad Money' Recap (Wednesday 2/1/17)

Winners and Losers in the Wake of Apple's Earnings: Cramer's 'Mad Money' Recap (Wednesday 2/1/17)

Jim Cramer details the impact of Apple's earnings on the whole economic ecosystem, and says Apple is the new mall.

Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs

Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs

Cannabis stocks are not affected by the volatility in prices during earnings season and instead trade on positive data such as potential FDA approval on their pipeline of drugs.

First Week of March 17th Options Trading For Cara Therapeutics (CARA)

First Week of March 17th Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options begin trading this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CARA options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017

Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017

Investors seeking less volatility can reap better returns in 2017 by allocating funds in sectors such as technology, biotech, energy and financials, which should generate above average performance.

Short Interest Makes 17.5% Move For CARA

Short Interest Makes 17.5% Move For CARA

The most recent short interest data has been released for the 12/15/2016 settlement date, which shows a 746,049 share increase in total short interest for Cara Therapeutics Inc , to 5,008,642, an increase of 17.50% since 11/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of August 2017 Options Trading For Cara Therapeutics (CARA)

First Week of August 2017 Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options begin trading this week, for the August 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Canadian Marijuana Market More Mature, Outperforms U.S. Market

Canadian Marijuana Market More Mature, Outperforms U.S. Market

The Canadian marijuana market is poised for growth as the number of registered patients continues grows and as licensed producers find innovative ways to create value for its shareholders.

The Pockets of Speculative Action Have Dried Up

The Pockets of Speculative Action Have Dried Up

There simply aren't many compelling trades on my screen.

First Week of January 2017 Options Trading For Cara Therapeutics (CARA)

First Week of January 2017 Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options begin trading this week, for the January 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CARA options chain for the new January 2017 contracts and identified one put and one call contract of particular interest.

No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass

No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass

In highlights from this week's trading diary and posts, Kass tells us about how to say no to closed-end muni bond funds and why Cara Therapeutics is on a run.

Short Interest Moves 42.2% Higher For CARA

Short Interest Moves 42.2% Higher For CARA

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 1,134,942 share increase in total short interest for Cara Therapeutics Inc , to 3,823,221, an increase of 42.22% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes

Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes

Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.

Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use

Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use

The volume of cannabis stocks listed on the Nasdaq have spiked ahead of the election as voters decide tomorrow on recreational and medical use of marijuana.

First Week of December 16th Options Trading For Cara Therapeutics Inc (CARA)

First Week of December 16th Options Trading For Cara Therapeutics Inc (CARA)

Investors in Cara Therapeutics Inc saw new options become available this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CARA options chain for the new December 16th contracts and identified one put and one call contract of particular interest.

Cara Therapeutics To Host Industry Symposium At The Orthopaedic Trauma Association 2016 Annual Meeting

Cara Therapeutics To Host Industry Symposium At The Orthopaedic Trauma Association 2016 Annual Meeting

Pain experts to discuss developments in kappa opioid receptor agonists and the future of chronic and acute pain management

Short Interest Jumps 34.4% For CARA

Short Interest Jumps 34.4% For CARA

The most recent short interest data has been released for the 08/31/2016 settlement date, which shows a 525,551 share increase in total short interest for Cara Therapeutics Inc , to 2,054,444, an increase of 34.37% since 08/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Here's Why Investors Should Steer Clear of Opioids

Here's Why Investors Should Steer Clear of Opioids

Backed by the government, initiatives to develop and popularize non-opioid painkillers can make investors high on profits.

TheStreet Quant Rating: D (Sell)